ArticleScientific reports2025

Blocking mineralocorticoid signaling with esaxerenone reduces atherosclerosis in hyperglycemic ApoE KO mice without affecting blood pressure and glycolipid metabolism.

Hideyuki Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.